| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 2,549,000 | 2,612,000 | 2,526,000 | 3,606,000 | | Cost of Revenue | 2,048,000 | 2,101,000 | 1,999,000 | 2,817,000 | | | Gross Profit | 501,000 | 511,000 | 527,000 | 789,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 185,000 | 503,000 | 346,000 | 412,000 | | Non Recurring | 42,000 | 129,000 | (18,000) | 425,000 | | Others |
-
| (76,000) | 76,000 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 274,000 | (45,000) | 123,000 | (48,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (206,000) |
-
|
-
| (234,000) | | Earnings Before Interest And Taxes | 68,000 | (45,000) | 123,000 | (282,000) | | Interest Expense | 73,000 | 75,000 | 82,000 | 114,000 | | Income Before Tax | (5,000) | (120,000) | 41,000 | (396,000) | | Income Tax Expense | (11,000) | (58,000) | (2,000) | (48,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,000 | (62,000) | 43,000 | (348,000) | | | Non-recurring Events | | Discontinued Operations | (2,000) | 4,000 | 43,000 | 139,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,000 | (58,000) | 86,000 | (209,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,000 | ($58,000) | $86,000 | ($209,000) |
|
1.52% Nasdaq 0.00%
Income Statement
